Clinical Trial Update: Trial to Reduce Alloimmunization to Platelets (TRAP) [Phase 3]

View source ↗

Summary

Phase 3 trial TRAP investigating reduction of alloimmunization to platelets has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Platelets, Hematologic Diseases | Phase 3 | Status: COMPLETED